UNAIDS/WHO Working Group on Global HIV/AIDS and STD Surveillance. Report on the Global HIV/AIDS Epidemic. Geneva, Switzerland: World Health Organization; December 1997:1-13.
Centers for Disease Control and Prevention. HIV/AIDS Surveillance Report. Atlanta, Ga: Centers for Disease Control and Prevention; 1997;9(2):5-43.
Clark SJ, Saag MS, Decker WD.
et al. High titers of cytopathic virus in plasma of patients with symptomatic
primary HIV-1 infection. N Engl J Med.1991;324:954-960.
Kinloch-de Loës S, Hirschel BJ, Hoen B.
et al. A controlled trial of zidovudine in primary human immunodeficiency
virus infection. N Engl J Med.1995;333:408-413.
Piatak M, Saag MS, Yang LC.
et al. High levels of HIV-1 in plasma during all stages of infection determined
by competitive PCR. Science.1993;259:1749-1754.
Schacker T, Collier AC, Hughes J, Shea T, Corey L. Clinical and epidemiologic features of primary HIV infection. Ann Intern Med.1996;125:257-264.
Tindall B, Barker S, Donovan B.
et al. Characterization of the acute clinical illness associated with human
immunodeficiency virus infection. Arch Intern Med.1988;148:945-949.
Centers for Disease Control and Prevention. National HIV Serosurveillance Summary: Results Through 1992 . Atlanta, Ga: US Dept of Health and Human Services;1994;3:1-51.
Kingsley LA, Zhou SYJ, Bacellar H.
et al. Temporal trends in human immunodeficiency virus type 1 seroconversion
1984-1989. Am J Epidemiol.1991;134:331-339.
Des Jarlais DC, Friedman SR, Sotheran JL.
et al. Continuity and change within an HIV epidemic: injecting drug users
in New York City, 1984 through 1992. JAMA.1994;271:121-127.
Weinstock HS, Sweeney S, Steinberg S, Gwinn M. HIV seroincidence among persons attending sexually transmitted disease
(STD) clinics in the United States, 1988-1995. In: Abstracts of the XI International Conference on AIDS; Vancouver,
British Columbia; July 7-12, 1996. Abstract Tu.C.2409;1:336.
Torian LV, Murrill CS, Makki HA.
et al. High HIV seroincidence in nonwhite bisexual men making repeat visits
to a New York City sexually transmitted disease clinic, 1994-1995: results
of a blinded longitudinal study. In: Program and abstracts of the 4th Conference on Retroviruses and
Opportunistic Infections; Washington, DC; January 22-26, 1997. Abstract 177:97.
Brookmeyer R, Quinn T, Shepherd M, Mehendale S, Rodrigues J, Bollinger R. The AIDS epidemic in India: a new method for estimating current human
immunodeficiency virus (HIV) incidence rates. Am J Epidemiol.1995;142:709-713.
Brookmeyer R, Quinn TC. Estimation of current human immunodeficiency virus incidence rates
from a cross-sectional survey using early diagnostic tests. Am J Epidemiol.1995;141:166-172.
Beyrer C, Brookmeyer R, Natpratan C.
et al. Measuring HIV-1 incidence in Northern Thailand: prospective cohort
results and estimates based on early diagnostic tests. J Acquir Immune Defic Syndr Hum Retrovirol.1996;12:495-499.
Busch MP, Lee LL, Satten GA.
et al. Time course of detection of viral and serologic markers preceding human
immunodeficiency virus type 1 seroconversion: implications for screening of
blood and tissue donors. Transfusion.1995;35:91-97.
Cooper DA, Imrie AA, Penny R. Antibody response to human immunodeficiency virus after primary infection. J Infect Dis.1987;155:1113-1118.
Lange JMA, Parry JV, de Wolf F, Mortimer PP, Goudsmit J. Diagnostic value of specific IgM antibodies in primary HIV infection. AIDS.1988;2:31-35.
McDougal JS, Kennedy MS, Nicholson JKA.
et al. Antibody response to human immunodeficiency virus in homosexual men. J Clin Invest.1987;80:316-324.
Lilienfeld AM, Lilienfeld DE. Foundations of Epidemiology . 2nd ed. New York, NY: Oxford University Press; 1976.
Not Available. Enzyme immunoassay for the detection of antibody to human immunodeficiency
virus type 1 (HIV-1) in human serum or plasma [package insert]. Abbott Park, Ill: Abbott Laboratories; 1994.
Centers for Disease Control. Interpretation and use of the Western blot assay for sero-diagnosis
of human immunodeficiency virus type 1 infections. MMWR Morb Mortal Wkly Rep.1989;38(suppl 7):1-7.
Cleghorn FR, Jack N, Greenberg M.
et al. Primary HIV-1 infection in Trinidad: clinical, immunologic and virologic
correlates. Paper presented at: 2nd National Conference on Human Retroviruses
and Related Infections; Washington, DC; January 30, 1995. Abstract 14:57.
Cleghorn FR, Greenberg M, O'Brien T.
et al. A heterosexually transmitted HIV-1 epidemic of subtype B in Trinidad. Paper presented at: 3rd Conference on Retroviruses and Opportunistic
Infections; Washington, DC; January 31, 1996. Abstract 509:147.
Winkelstein Jr W, Lyman DM, Padian N.
et al. Sexual practices and risk of infection by the human immunodeficiency
virus: the San Francisco Men's Health Study. JAMA.1987;257:321-325.
Winkelstein Jr W, Samuel M, Padian N.
et al. The San Francisco Men's Health Study, III: reduction in human immunodeficiency
virus transmission among homosexual/bisexual men, 1982-86. Am J Public Health.1987;77:685-689.
Winkelstein Jr W, Wiley JA, Padian N.
et al. The San Francisco Men's Health Study: continued decline in HIV seroconversion
rates among homosexual/bisexual men. Am J Public Health.1988;78:1472-1474.
Snedecor GW, Cochran WG. Statistical Methods . 6th ed. Ames: Iowa State University Press; 1967.
Dempster AP, Laird NM, Rubin DB. Maximum likelihood from incomplete data via the EM algorithm. J R Stat Soc B.1977;39:1-38.
Silverman BW, Jones MC, Wilson JD, Nychka DW. A smoothed EM approach to indirect estimation problems, with particular
reference to sterology and emission tomography. J R Stat Soc B.1990;52:271-324.
Efron B, Tibshirani RJ. An Introduction to the Bootstrap . New York, NY: Chapman & Hall; 1993.
Zuck TF, Thomson RA, Schreiber GB.
et al. The Retrovirus Epidemiology Study (REDS): rationale and methods. Transfusion.1995;35:944-951.
Sayre KR, Dodd RY, Tegtmeier G, Layug L, Alexander SS, Busch MP. False-positive human immunodeficiency virus type 1 Western blot tests
in noninfected blood donors. Transfusion.1996;36:45-52.
Chambers JM, Cleveland WS, Kleiner B, Tukey PA. Graphical Methods for Data Analysis . Belmont, Calif: Wadsworth; 1983.
Turnbull B. The empirical distribution function with arbitrarily grouped, censored,
and truncated data. J R Stat Soc B.1976;38:290-295.
Brookmeyer R. Reconstruction and future trends of the AIDS epidemic in the United
Bacchetti P, Segal M, Jewell NP. Backcalculation of HIV infection rates. Stat Sci.1993;8:82-119.
Rosenberg PS. Scope of the AIDS epidemic in the United States. Science.1995;270:1372-1375.
Centers for Disease Control and Prevention. 1993 Revised classification system for HIV infection and expanded surveillance
case definition for AIDS among adolescents and adults. MMWR Morb Mortal Wkly Rep.1992;41(RR-17):1-19.
Ho DD. Time to hit HIV, early and hard. N Engl J Med.1995;333:450-451.
Carpenter CCJ, Fischl MA, Hammer S.
et al. Antiretroviral therapy for HIV infection in 1997: updated recommendations
of the International AIDS Society–USA panel. JAMA.1997;277:1962-1969.
Perelson AS, Neumann AU, Markowitz M, Leonard JM, Ho DD. HIV-1 dynamics in vivo: virion clearance rate, infected cell life-span,
and viral generation time. Science.1996;271:1582-1586.
Quinn TC. Acute primary HIV infection. JAMA.1997;278:58-62.
Kahn JO, Walker BD. Acute HIV-1 infection syndrome: a review. N Engl J Med.In press.
Niu MT, Stein DS, Schnittman SM. Primary human immunodeficiency virus type 1 infection: review of pathogenesis
and early treatment intervention in human and animal retrovirus infection. J Infect Dis.1993;168:1490-1501.
Kinloch-de Loës S, de Saussure P, Saurat JH, Stadler H, Hirschel B, Perrin LH. Symptomatic primary infection due to human immunodeficiency virus type
1: review of 31 cases. Clin Infect Dis.1993;17:59-65.
Rosenberg ES, Billingsley JM, Caliendo AM.
et al. Vigorous HIV-1-specific CD4+ T cell responses associated
with control of viremia. Science.1997;278:1447-1450.
Markowitz M, Cao Y, Vesanen M.
et al. Recent HIV-1 infection treated with AZT, 3TC, and a potent protease
inhibitor. In: Program and abstracts of the 4th Conference on Retroviruses and
Opportunistic Infections; Washington, DC; January 2226, 1997. Abstract LB8:207.
Pantaleo G, Cohen OJ, Schacker T.
et al. Evolutionary pattern of human immunodeficiency virus (HIV) replication
and distribution in lymph nodes following primary infection: implications
for antiviral therapy. Nat Med.1998;4:341-345.
Conway B, Montessori V, Montaner J, Shillington A, Fransen S, Rouleau D. Use of saquinavir-containing regimens for the treatment of primary
HIV infection. In: Program and abstracts of the 5th Conference on Retroviruses and
Opportunistic Infections; Chicago, Ill; February 1-5, 1998. Abstract 583:189.
Saget B, Goodenow M, Christopherson C, Sninsky J, Kwok S, Scheibel S. Aggressive treatment of recent HIV-1 infected subjects with prolonged
undetectable HIV-1 plasma RNA is associated with low levels of HIV-1 proviral
DNA. In: Program and abstracts of the 5th Conference on Retroviruses and
Opportunistic Infections; Chicago, Ill; February 1-5, 1998. Abstract 584:189.
Mellors JW, Kingsley LA, Rinaldo CR.
et al. Quantitation of HIV-1 RNA in plasma predicts outcome after seroconversion. Ann Intern Med.1995;122:573-579.
O'Brien TR, Busch MP, Donegan E.
et al. Heterosexual transmission of human immunodeficiency virus type 1 from
transfusion recipients to their sex partners. J Acquir Immune Defic Syndr.1994;7:705-710.
Jacquez JA, Koopman JS, Simon CP, Longini Jr IM. Role of the primary infection in epidemics of HIV infection in gay
cohorts. J Acquir Immune Defic Syndr.1994;7:1169-1184.
Rothenberg RB, Narramore J. The relevance of social network concepts to sexually transmitted disease
control. Sex Transm Dis.1996;23:24-29.
Satten GA. Steady-state calculation of the risk of HIV infection from transfusion
of screened blood from repeat donors. Math Biosci.1997;141:101-113.